severe aplastic anaemia

• Healthcare
• Marketing
• Pharma & Biotech
• United Kingdom

GSK submits variation to the Marketing Authorisation for eltrombopag (Revolade™) to the European Medicines Agency (EMA)

LONDON, 13-11-2014 — /EuropaWire/ — GSK today announced the submission to the European Medicines Agency (EMA) of a variation to…